• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例尽管接受预防性抗凝治疗仍并发静脉血栓栓塞症的新型冠状病毒肺炎病例

A Case of COVID-19 Complicated by Venous Thromboembolism Despite Being on Prophylactic Anticoagulation.

作者信息

Rout Amit, Chan Abigail

机构信息

Department of Internal Medicine, Sinai Hospital of Baltimore, Baltimore, MD 21215, USA.

出版信息

J Med Cases. 2020 Jul;11(7):189-191. doi: 10.14740/jmc3500. Epub 2020 Jun 18.

DOI:10.14740/jmc3500
PMID:33984078
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8040433/
Abstract

The coronavirus disease 2019 (COVID-19) presents with variable clinical syndromes, from asymptomatic disease to acute respiratory failure. Complications such as acute respiratory distress syndrome (ARDS), secondary infection, acute cardiac injury, liver failure, renal failure, coagulable disorders and in many cases, death have been recognized. Venous thromboembolism (VTE) was found to be present in up to one-third of critically ill COVID-19 patients. Our case demonstrated a patient with COVID-19 who developed a massive pulmonary embolism leading to cardiac arrest, despite having an initial normal D-dimer level, normal chest imaging, and while maintained on appropriate VTE prophylaxis during hospitalization.

摘要

2019冠状病毒病(COVID-19)表现出多种临床综合征,从无症状感染到急性呼吸衰竭。已认识到诸如急性呼吸窘迫综合征(ARDS)、继发感染、急性心脏损伤、肝衰竭、肾衰竭、凝血障碍等并发症,在许多情况下还会导致死亡。研究发现,高达三分之一的重症COVID-19患者存在静脉血栓栓塞(VTE)。我们的病例显示,一名COVID-19患者发生了大面积肺栓塞,导致心脏骤停,尽管其最初D-二聚体水平正常、胸部影像学检查正常,且在住院期间一直接受适当的VTE预防治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/8383626/dc70b36b68ba/jmc-11-189-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/8383626/b60f05a130f6/jmc-11-189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/8383626/f8d63b941035/jmc-11-189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/8383626/dc70b36b68ba/jmc-11-189-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/8383626/b60f05a130f6/jmc-11-189-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/8383626/f8d63b941035/jmc-11-189-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3e4/8383626/dc70b36b68ba/jmc-11-189-g003.jpg

相似文献

1
A Case of COVID-19 Complicated by Venous Thromboembolism Despite Being on Prophylactic Anticoagulation.一例尽管接受预防性抗凝治疗仍并发静脉血栓栓塞症的新型冠状病毒肺炎病例
J Med Cases. 2020 Jul;11(7):189-191. doi: 10.14740/jmc3500. Epub 2020 Jun 18.
2
COVID-19 Infection in Critically Ill Patients Carries a High Risk of Venous Thrombo-embolism.危重症患者感染新型冠状病毒肺炎后发生静脉血栓栓塞的风险很高。
Eur J Vasc Endovasc Surg. 2021 Apr;61(4):628-634. doi: 10.1016/j.ejvs.2020.12.015. Epub 2020 Dec 23.
3
Venous thromboembolism in critically ill patients affected by ARDS related to COVID-19 in Northern-West Italy.意大利西北部 COVID-19 相关急性呼吸窘迫综合征危重症患者的静脉血栓栓塞症。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):9154-9160. doi: 10.26355/eurrev_202009_22864.
4
Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.经验性系统性抗凝与危重症甲型 H1N1 流感急性呼吸窘迫综合征患者的静脉血栓栓塞减少相关。
J Vasc Surg Venous Lymphat Disord. 2019 May;7(3):317-324. doi: 10.1016/j.jvsv.2018.08.010. Epub 2018 Nov 23.
5
Venous Thromboembolism Has a Variable Time of Occurrence in the Course of COVID-19: A Case Series.静脉血栓栓塞在COVID-19病程中的发生时间具有变异性:病例系列
Cureus. 2020 Dec 26;12(12):e12295. doi: 10.7759/cureus.12295.
6
Venous Thromboembolism in Hospitalized COVID-19 Patients.住院 COVID-19 患者中的静脉血栓栓塞症。
Am J Ther. 2020 Nov/Dec;27(6):e599-e610. doi: 10.1097/MJT.0000000000001295.
7
Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis.接受血栓预防的COVID-19住院患者的静脉血栓栓塞:一项系统评价和荟萃分析
J Clin Med. 2020 Aug 3;9(8):2489. doi: 10.3390/jcm9082489.
8
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.用于预测危重症 COVID-19 患者静脉血栓栓塞症的生物标志物。
Thromb Res. 2020 Dec;196:308-312. doi: 10.1016/j.thromres.2020.09.017. Epub 2020 Sep 15.
9
Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society.《COVID-19 大流行期间波兰静脉血栓栓塞症抗凝管理指南:波兰心脏病学会肺循环分会专家意见》
Kardiol Pol. 2020 Jun 25;78(6):642-646. doi: 10.33963/KP.15425. Epub 2020 Jun 8.
10
Acute Pulmonary Embolism in COVID-19: A Report of Two Cases.新型冠状病毒肺炎相关急性肺栓塞:两例报告
Cureus. 2020 Jul 29;12(7):e9459. doi: 10.7759/cureus.9459.

引用本文的文献

1
Pulmonary Thrombosis despite Therapeutic Anticoagulation in COVID-19 Pneumonia: A Case Report and Literature Review.COVID-19 肺炎治疗性抗凝后发生肺血栓栓塞症:病例报告及文献复习。
Viruses. 2023 Jul 12;15(7):1535. doi: 10.3390/v15071535.
2
COVID-19 and venous thromboembolism risk in patients with sickle cell disease.COVID-19 与镰状细胞病患者的静脉血栓栓塞风险。
Blood Adv. 2022 Aug 9;6(15):4408-4412. doi: 10.1182/bloodadvances.2022007219.

本文引用的文献

1
Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection.新型冠状病毒肺炎(COVID-19)感染患者的异常止血参数与血栓栓塞风险
J Hematol. 2020 Apr;9(1-2):1-4. doi: 10.14740/jh636. Epub 2020 Apr 23.
2
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会(ISTH)关于新冠病毒病(COVID-19)凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
3
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.
COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
4
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.新型冠状病毒肺炎重型患者静脉血栓栓塞症发病情况。
J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.
5
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
6
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.